Recent Cancer Papers

Systematic functional interrogation of rare cancer variants identifies oncogenic alleles.Kim, E., Ilic N., Shrestha Y., Zou L., Kamburov A., Zhu C., Yang X., Lubonja R., Tran N., Nguyen C., Lawrence MS, Piccioni F., Bagul M., Doench JG, Chouinard CR, Wu X., Hogstrom L., Natoli T., Tamayo P., Horn H., et al. Cancer discovery, 2016/05/04, (2016) Read More / View Supplemental Materials
Abstract
Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors.Kim, J., Mouw KW, Polak P., Braunstein LZ, Kamburov A., Tiao G., Kwiatkowski DJ, Rosenberg JE, Van Allen EM, D'Andrea AD, and Getz G. Nature genetics, 2016/04/25, (2016) Read More / View Supplemental Materials
Abstract
Characterizing genomic alterations in cancer by complementary functional associations.Kim, JW, Botvinnik OB, Abudayyeh O., Birger C., Rosenbluh J., Shrestha Y., Abazeed ME, Hammerman PS, Dicara D., Konieczkowski DJ, Johannessen CM, Liberzon A., Alizad-Rahvar AR, Alexe G., Aguirre A., Ghandi M., Greulich H., Vazquez F., Weir BA, Van Allen EM, et al. Nature biotechnology, 2016/04/18, (2016) Read More / View Supplemental Materials
Abstract
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq.Tirosh, I., Izar B., Prakadan SM, Wadsworth MH 2nd, Treacy D., Trombetta JJ, Rotem A., Rodman C., Lian C., Murphy G., Fallahi-Sichani M., Dutton-Regester K., Lin JR, Cohen O., Shah P., Lu D., Genshaft AS, Hughes TK, Ziegler CG, Kazer SW, et al. Science (New York, N.Y.), 2016/04/08, Volume 352, Issue 6282, p.189-96, (2016) Read More / View Supplemental Materials
Abstract
Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML.Puram, RV, Kowalczyk MS, de Boer CG, Schneider RK, Miller PG, McConkey M., Tothova Z., Tejero H., Heckl D., Järås M., Chen MC, Li H., Tamayo A., Cowley GS, Rozenblatt-Rosen O., Al-Shahrour F., Regev A., and Ebert BL Cell, 2016/04/07, Volume 165, Issue 2, p.303-16, (2016) Read More / View Supplemental Materials
Abstract
Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9.Schneider, RK, Schenone M., Ferreira MV, Kramann R., Joyce CE, Hartigan C., Beier F., Brümmendorf TH, Germing U., Platzbecker U., Büsche G., Knüchel R., Chen MC, Waters CS, Chen E., Chu LP, Novina CD, Lindsley RC, Carr SA, and Ebert BL Nature medicine, 2016/03/01, Volume 22, Issue 3, p.288-97, (2016) Read More / View Supplemental Materials
Abstract
High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines.Yu, C., Mannan AM, Yvone GM, Ross KN, Zhang YL, Marton MA, Taylor BR, Crenshaw A., Gould JZ, Tamayo P., Weir BA, Tsherniak A., Wong B., Garraway LA, Shamji AF, Palmer MA, Foley MA, Winckler W., Schreiber SL, Kung AL, et al. Nature biotechnology, 2016/02/29, (2016) Read More / View Supplemental Materials
Abstract
MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells.Kryukov, GV, Wilson FH, Ruth JR, Paulk J., Tsherniak A., Marlow SE, Vazquez F., Weir BA, Fitzgerald ME, Tanaka M., Bielski CM, Scott JM, Dennis C., Cowley GS, Boehm JS, Root DE, Golub T. R., Clish CB, Bradner JE, Hahn WC, et al. Science (New York, N.Y.), 2016/02/11, (2016) Read More / View Supplemental Materials
Abstract
Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study.Gray, SW, Park ER, Najita J., Martins Y., Traeger L., Bair E., Gagne J., Garber J., Jänne PA, Lindeman N., Lowenstein C., Oliver N., Van Allen EM, Wagle N., Garraway L., and Joffe S. Genetics in medicine : official journal of the American College of Medical Genetics, 2016/02/11, (2016) Read More / View Supplemental Materials
Abstract
Identification of an "Exceptional Responder" Cell Line to MEK1 Inhibition: Clinical Implications for MEK-Targeted Therapy.Gannon, HS, Kaplan N., Tsherniak A., Vazquez F., Weir BA, Hahn WC, and Meyerson M. Molecular cancer research : MCR, 2016/02/01, Volume 14, Issue 2, p.207-15, (2016) Read More / View Supplemental Materials
Abstract
Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics.de Waal, L., Lewis TA, Rees MG, Tsherniak A., Wu X., Choi PS, Hartigan C., Faloon PW, Hickey MJ, Tolliday N., Carr SA, Clemons PA, Munoz B., Wagner BK, Shamji AF, Koehler AN, Schenone M., Burgin AB, Schreiber SL, Greulich H., et al. Nature chemical biology, 2016/02/01, Volume 12, Issue 2, p.102-8, (2016) Read More / View Supplemental Materials
Abstract
Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair.Haradhvala, NJ, Polak P., Stojanov P., Covington KR, Shinbrot E., Hess JM, Rheinbay E., Kim J., Maruvka YE, Braunstein LZ, Kamburov A., Hanawalt PC, Wheeler DA, Koren A., Lawrence MS, and Getz G. Cell, 2016/01/20, (2016) Read More / View Supplemental Materials
Abstract
Targetable genetic features of primary testicular and primary central nervous system lymphomas.Chapuy, B., Roemer MG, Stewart C., Tan Y., Abo RP, Zhang L., Dunford AJ, Meredith DM, Thorner AR, Jordanova ES, Liu G., Feuerhake F., Ducar MD, Illerhaus G., Gusenleitner D., Linden EA, Sun HH, Homer H., Aono M., Pinkus GS, et al. Blood, 2015/12/23, (2015) Read More / View Supplemental Materials
Abstract
Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers.Zhang, X., Choi PS, Francis JM, Imielinski M., Watanabe H., Cherniack AD, and Meyerson M. Nature genetics, 2015/12/14, (2015) Read More / View Supplemental Materials
Abstract
TERT promoter mutations and monoallelic activation of TERT in cancer.Huang, FW, Bielski CM, Rinne ML, Hahn WC, Sellers WR, Stegmeier F., Garraway LA, and Kryukov GV Oncogenesis, 2015/12/14, Volume 4, p.e176, (2015) Read More / View Supplemental Materials
Abstract
Pharmacogenomic agreement between two cancer cell line data sets.Cancer Cell Line Encyclopedia, Consortium, and Genomics of Drug Sensitivity in Cancer Consortium Nature, 2015/12/03, Volume 528, Issue 7580, p.84-7, (2015) Read More / View Supplemental Materials
Abstract
The genomic landscape of juvenile myelomonocytic leukemia.Stieglitz, E., Taylor-Weiner AN, Chang TY, Gelston LC, Wang YD, Mazor T., Esquivel E., Yu A., Seepo S., Olsen SR, Rosenberg M., Archambeault SL, Abusin G., Beckman K., Brown PA, Briones M., Carcamo B., Cooper T., Dahl GV, Emanuel PD, et al. Nature genetics, 2015/11/01, Volume 47, Issue 11, p.1326-33, (2015) Read More / View Supplemental Materials
Abstract
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis.Pomerantz, MM, Li F., Takeda DY, Lenci R., Chonkar A., Chabot M., Cejas P., Vazquez F., Cook J., Shivdasani RA, Bowden M., Lis R., Hahn WC, Kantoff PW, Brown M., Loda M., Long HW, and Freedman ML Nature genetics, 2015/11/01, Volume 47, Issue 11, p.1346-51, (2015) Read More / View Supplemental Materials
Abstract
Mutations driving CLL and their evolution in progression and relapse.Landau, DA, Tausch E., Taylor-Weiner AN, Stewart C., Reiter JG, Bahlo J., Kluth S., Bozic I., Lawrence M., Böttcher S., Carter SL, Cibulskis K., Mertens D., Sougnez CL, Rosenberg M., Hess JM, Edelmann J., Kless S., Kneba M., Ritgen M., et al. Nature, 2015/10/22, Volume 526, Issue 7574, p.525-30, (2015) Read More / View Supplemental Materials
Abstract
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma.Van Allen, EM, Miao D., Schilling B., Shukla SA, Blank C., Zimmer L., Sucker A., Hillen U., Foppen MH, Goldinger SM, Utikal J., Hassel JC, Weide B., Kaehler KC, Loquai C., Mohr P., Gutzmer R., Dummer R., Gabriel S., Wu CJ, et al. Science (New York, N.Y.), 2015/10/09, Volume 350, Issue 6257, p.207-11, (2015) Read More / View Supplemental Materials
Abstract
Comprehensive assessment of cancer missense mutation clustering in protein structures.Kamburov, A., Lawrence MS, Polak P., Leshchiner I., Lage K., Golub T. R., Lander E. S., and Getz G. Proceedings of the National Academy of Sciences of the United States of America, 2015/10/06, Volume 112, Issue 40, p.E5486-95, (2015) Read More / View Supplemental Materials
Abstract
Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma.Kennedy, AL, Vallurupalli M., Chen L., Crompton B., Cowley G., Vazquez F., Weir BA, Tsherniak A., Parasuraman S., Kim S., Alexe G., and Stegmaier K. Oncotarget, 2015/10/06, Volume 6, Issue 30, p.30178-93, (2015) Read More / View Supplemental Materials
Abstract
The novel mechanism of lenalidomide activity.Fink, EC, and Ebert BL Blood, 2015/10/05, (2015) Read More / View Supplemental Materials
Abstract
Combined pan-RAF and MEK inhibition overcomes multiple resistance mechanisms to selective RAF inhibitors.Whittaker, SR, Cowley GS, Wagner S., Root DE, and Garraway LA Molecular cancer therapeutics, 2015/09/08, (2015) Read More / View Supplemental Materials
Abstract